AZILSARTAN KAMEDOXOMIL

AZILSARTAN KAMEDOXOMIL was reported 3052 times

AZILSARTAN KAMEDOXOMIL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PERITONITIS LUPUS 2 0.1667
1 FOCAL PERITONITIS 5 0.0806
2 PLEURISY BACTERIAL 3 0.0732
3 PERSISTENT POSTURAL-PERCEPTUAL DIZZINESS 2 0.0513
4 ADMINISTRATION SITE HAEMATOMA 2 0.0500
5 HYPERADRENALISM 3 0.0246
6 LOSS OF BLADDER SENSATION 4 0.0245
7 HYPOPHARYNGEAL CANCER 2 0.0238
8 COUGH VARIANT ASTHMA 2 0.0238
9 KL-6 INCREASED 5 0.0221
10 WITHDRAWAL HYPERTENSION 4 0.0198
11 CRYPTOCOCCAL MENINGOENCEPHALITIS 2 0.0153
12 SUSPECTED DRUG-INDUCED LIVER INJURY 3 0.0150
13 IMMOBILISATION SYNDROME 3 0.0141
14 ZINC DEFICIENCY 3 0.0140
15 RESPIRATORY MUSCLE WEAKNESS 4 0.0123
16 THROMBOTIC CEREBRAL INFARCTION 4 0.0106
17 PSEUDOALDOSTERONISM 2 0.0101
18 SHUNT OCCLUSION 5 0.0098
19 PRODUCT CLOSURE REMOVAL DIFFICULT 8 0.0078
20 IMMUNE-MEDIATED ADRENAL INSUFFICIENCY 6 0.0075
21 DYSLALIA 5 0.0069
22 FULMINANT TYPE 1 DIABETES MELLITUS 7 0.0068
23 MICROANGIOPATHY 6 0.0064
24 GASTROENTERITIS EOSINOPHILIC 2 0.0059
25 IMMUNE-MEDIATED CHOLANGITIS 2 0.0056
26 CHOLANGITIS ACUTE 4 0.0053
27 DISSEMINATED CRYPTOCOCCOSIS 4 0.0053
28 MECHANICAL ILEUS 3 0.0053
29 CYTOMEGALOVIRUS ENTEROCOLITIS 4 0.0052
30 BRASH SYNDROME 7 0.0050
31 IMMUNE-MEDIATED RENAL DISORDER 2 0.0048
32 GIANT CELL ARTERITIS 4 0.0048
33 LYMPHANGIOSIS CARCINOMATOSA 5 0.0048
34 OCULOMUCOCUTANEOUS SYNDROME 2 0.0047
35 THALAMUS HAEMORRHAGE 4 0.0046
36 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 4 0.0046
37 PRODUCT ODOUR ABNORMAL 43 0.0041
38 IMMUNE-MEDIATED THYROIDITIS 2 0.0040
39 PRODUCT COMMINGLING 4 0.0038
40 METABOLIC ALKALOSIS 6 0.0037
41 IMMUNE-MEDIATED HYPOTHYROIDISM 4 0.0035
42 LYMPHOCYTE MORPHOLOGY ABNORMAL 2 0.0035
43 MALE SEXUAL DYSFUNCTION 2 0.0033
44 IMMUNE-MEDIATED LUNG DISEASE 6 0.0033
45 RENAL ATROPHY 4 0.0032
46 PNEUMONIA CRYPTOCOCCAL 3 0.0032
47 PYELOCALIECTASIS 3 0.0031
48 IMMUNE-MEDIATED HEPATIC DISORDER 6 0.0031
49 SUBCUTANEOUS EMPHYSEMA 3 0.0031
50 SPUTUM RETENTION 3 0.0030
51 IMMUNE-MEDIATED ENTEROCOLITIS 11 0.0030
52 HEAT ILLNESS 2 0.0030
53 URETEROLITHIASIS 3 0.0029
54 PRERENAL FAILURE 4 0.0028
55 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
56 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 7 0.0028
57 CHOLANGITIS 17 0.0027
58 SINUS NODE DYSFUNCTION 5 0.0027
59 CENTRAL OBESITY 2 0.0027
60 HYPERGLYCAEMIC HYPEROSMOLAR NONKETOTIC SYNDROME 3 0.0027
61 ARTERIAL INJURY 2 0.0027
62 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 3 0.0027
63 SECONDARY ADRENOCORTICAL INSUFFICIENCY 4 0.0026
64 GINGIVAL HYPERTROPHY 4 0.0026
65 ADMINISTRATION SITE PAIN 3 0.0026
66 MYASTHENIC SYNDROME 2 0.0026
67 IMMUNE-MEDIATED MYOSITIS 7 0.0025
68 HYPERPARATHYROIDISM SECONDARY 6 0.0024
69 PHYSICAL DECONDITIONING 6 0.0023
70 BLOOD PRESSURE INADEQUATELY CONTROLLED 14 0.0023
71 HYPOPITUITARISM 4 0.0023
72 GLOSSITIS 8 0.0023
73 AORTIC VALVE STENOSIS 4 0.0022
74 HYPERPLASIA 2 0.0022
75 GASTROINTESTINAL HYPOMOTILITY 5 0.0022
76 HYPERURICAEMIA 9 0.0022
77 ANEURYSM RUPTURED 2 0.0022
78 MUSCLE SWELLING 2 0.0022
79 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0022
80 NEPHROGENIC ANAEMIA 10 0.0022
81 LYMPH NODE PAIN 4 0.0021
82 BLADDER SPASM 4 0.0021
83 BLOOD UREA ABNORMAL 2 0.0021
84 CEREBELLAR HAEMORRHAGE 3 0.0021
85 LACUNAR INFARCTION 5 0.0021
86 RENAL INFARCT 3 0.0021
87 NORMOCYTIC ANAEMIA 3 0.0020
88 INTESTINAL ISCHAEMIA 11 0.0020
89 IMMUNE-MEDIATED DERMATITIS 2 0.0020
90 MARASMUS 3 0.0020
91 PRODUCT CONTAMINATION 7 0.0020
92 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4 0.0020
93 IMMUNE-MEDIATED HEPATITIS 4 0.0020
94 GLOMERULAR FILTRATION RATE DECREASED 24 0.0020
95 CAROTID ARTERIOSCLEROSIS 2 0.0019
96 LUNG OPACITY 5 0.0019
97 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
98 INNER EAR DISORDER 2 0.0019
99 IMMUNE-MEDIATED MYOCARDITIS 3 0.0019
100 PERIODONTITIS 4 0.0018
101 PNEUMONIA STREPTOCOCCAL 2 0.0018
102 PRODUCT SELECTION ERROR 2 0.0018
103 ADRENAL INSUFFICIENCY 22 0.0018
104 CHOLESTATIC LIVER INJURY 4 0.0018
105 DIVERTICULUM INTESTINAL HAEMORRHAGIC 4 0.0018
106 PNEUMATOSIS INTESTINALIS 5 0.0018
107 ENTEROCOLITIS 10 0.0017
108 VASCULAR PSEUDOANEURYSM 3 0.0017
109 PEMPHIGOID 13 0.0017
110 ENTERITIS 11 0.0017
111 HYPOCHLORAEMIA 2 0.0017
112 PROCALCITONIN INCREASED 2 0.0017
113 GLOMERULONEPHRITIS MEMBRANOUS 2 0.0017
114 POOR QUALITY DRUG ADMINISTERED 11 0.0017
115 HYPERTENSIVE EMERGENCY 2 0.0017
116 PNEUMONIA INFLUENZAL 2 0.0017
117 CEREBRAL INFARCTION 41 0.0017
118 HAEMATOMA MUSCLE 2 0.0017
119 MYASTHENIA GRAVIS 13 0.0016
120 INJECTION SITE ABSCESS 4 0.0016
121 GLUCOSE URINE PRESENT 2 0.0016
122 DACRYOSTENOSIS ACQUIRED 2 0.0015
123 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
124 INTERCEPTED PRODUCT PRESCRIBING ERROR 2 0.0015
125 SUDDEN HEARING LOSS 3 0.0015
126 CALCULUS BLADDER 2 0.0015
127 PROCTITIS 4 0.0014
128 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
129 PERIPHERAL ARTERY OCCLUSION 2 0.0014
130 VASCULAR OCCLUSION 3 0.0014
131 FANCONI SYNDROME 2 0.0014
132 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
133 JOINT LOCK 4 0.0014
134 CARDIAC FAILURE CHRONIC 6 0.0014
135 DUODENAL ULCER HAEMORRHAGE 4 0.0014
136 CORONARY ARTERY STENOSIS 7 0.0014
137 PYELONEPHRITIS 12 0.0014
138 INFECTION SUSCEPTIBILITY INCREASED 3 0.0014
139 INCORRECT PRODUCT STORAGE 18 0.0014
140 PROTEINURIA 26 0.0014
141 BLOOD POTASSIUM INCREASED 22 0.0014
142 BLOOD PARATHYROID HORMONE DECREASED 2 0.0013
143 ILEUS PARALYTIC 6 0.0013
144 THYROIDITIS 4 0.0013
145 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
146 BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0013
147 GASTRIC ULCER HAEMORRHAGE 7 0.0013
148 INTERMITTENT CLAUDICATION 2 0.0013
149 BILE DUCT STONE 4 0.0013
150 PREMATURE RUPTURE OF MEMBRANES 3 0.0012
151 THROMBOSIS IN DEVICE 4 0.0012
152 EUGLYCAEMIC DIABETIC KETOACIDOSIS 5 0.0012
153 ORGANISING PNEUMONIA 6 0.0012
154 CORONAVIRUS INFECTION 8 0.0012
155 AORTIC DISSECTION 5 0.0012
156 OLIGOHYDRAMNIOS 4 0.0012
157 RENAL IMPAIRMENT 100 0.0012
158 METASTASES TO PERITONEUM 3 0.0012
159 HYPOALBUMINAEMIA 9 0.0012
160 ATRIOVENTRICULAR BLOCK FIRST DEGREE 5 0.0012
161 GASTROINTESTINAL OEDEMA 2 0.0011
162 BREAST CYST 2 0.0011
163 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
164 JUGULAR VEIN THROMBOSIS 2 0.0011
165 INDURATION 2 0.0011
166 BLOOD SODIUM INCREASED 3 0.0011
167 PNEUMOMEDIASTINUM 2 0.0011
168 METASTATIC RENAL CELL CARCINOMA 2 0.0011
169 AMYLASE INCREASED 4 0.0011
170 CHOLECYSTITIS INFECTIVE 3 0.0011
171 CARDIAC DYSFUNCTION 4 0.0011
172 INTERSTITIAL LUNG DISEASE 52 0.0011
173 RENAL TUBULAR DISORDER 3 0.0011
174 HYPERKALAEMIA 37 0.0011
175 CARDIAC TAMPONADE 5 0.0011
176 CARDIAC FAILURE ACUTE 7 0.0010
177 ADRENAL DISORDER 2 0.0010
178 HAEMOTHORAX 3 0.0010
179 PERIPHERAL SENSORY NEUROPATHY 6 0.0010
180 CONCOMITANT DISEASE PROGRESSION 2 0.0010
181 NEPHROTIC SYNDROME 7 0.0010
182 SKIN ODOUR ABNORMAL 4 0.0010
183 PNEUMONIA FUNGAL 4 0.0010
184 PRODUCT DISPENSING ERROR 22 0.0010
185 PROTEIN URINE PRESENT 5 0.0010
186 HYPERCAPNIA 3 0.0010
187 PULMONARY TOXICITY 7 0.0010
188 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 23 0.0010
189 DYSLIPIDAEMIA 5 0.0010
190 EYELID PAIN 2 0.0010
191 SHOCK HAEMORRHAGIC 8 0.0010
192 MASTICATION DISORDER 3 0.0010
193 RECTAL CANCER 3 0.0010
194 ERYTHEMA MULTIFORME 9 0.0010
195 HEPATIC FUNCTION ABNORMAL 36 0.0010
196 TUBULOINTERSTITIAL NEPHRITIS 18 0.0010
197 EOSINOPHILIC PNEUMONIA 3 0.0010
198 FACIAL PARALYSIS 8 0.0009
199 HYDRONEPHROSIS 7 0.0009
200 RADIATION PNEUMONITIS 2 0.0009
201 COMPRESSION FRACTURE 5 0.0009
202 HYPERPHOSPHATAEMIA 2 0.0009
203 BACTERAEMIA 11 0.0009
204 ALTERED STATE OF CONSCIOUSNESS 20 0.0009
205 DIABETIC NEPHROPATHY 2 0.0009
206 BLOOD CREATINE INCREASED 4 0.0009
207 HIGH DENSITY LIPOPROTEIN DECREASED 3 0.0009
208 POTENTIATING DRUG INTERACTION 3 0.0009
209 PULMONARY ALVEOLAR HAEMORRHAGE 5 0.0009
210 CHRONIC GASTRITIS 2 0.0009
211 GASTRIC POLYPS 2 0.0009
212 DIABETIC RETINOPATHY 3 0.0009
213 HAEMOGLOBIN INCREASED 4 0.0009
214 HYPOTHYROIDISM 28 0.0009
215 IMMUNE THROMBOCYTOPENIA 4 0.0009
216 REACTION TO EXCIPIENT 2 0.0009
217 BLOOD URIC ACID INCREASED 5 0.0009
218 STRESS CARDIOMYOPATHY 5 0.0009
219 PUSTULE 2 0.0008
220 SYMPTOM RECURRENCE 5 0.0008
221 HUMERUS FRACTURE 4 0.0008
222 CUTANEOUS VASCULITIS 3 0.0008
223 THROMBOTIC MICROANGIOPATHY 8 0.0008
224 HAEMATOLOGICAL INFECTION 2 0.0008
225 RENAL CELL CARCINOMA 4 0.0008
226 DERMAL CYST 2 0.0008
227 FLUID INTAKE REDUCED 4 0.0008
228 CYTOKINE RELEASE SYNDROME 16 0.0008
229 APPENDICITIS PERFORATED 2 0.0008
230 ANGLE CLOSURE GLAUCOMA 2 0.0008
231 BLOOD PRESSURE DECREASED 52 0.0008
232 CANCER PAIN 2 0.0008
233 LACTOSE INTOLERANCE 2 0.0008
234 OESOPHAGEAL ULCER 3 0.0008
235 HYPERTENSION 165 0.0008
236 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
237 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
238 EPIGASTRIC DISCOMFORT 3 0.0008
239 COMPARTMENT SYNDROME 2 0.0008
240 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
241 PNEUMONIA BACTERIAL 7 0.0008
242 POOR QUALITY PRODUCT ADMINISTERED 8 0.0008
243 RENAL CYST 6 0.0008
244 METASTASES TO LYMPH NODES 5 0.0007
245 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 3 0.0007
246 BLOOD CREATININE INCREASED 47 0.0007
247 MYOCARDITIS 8 0.0007
248 PNEUMOCYSTIS JIROVECII PNEUMONIA 7 0.0007
249 FIBULA FRACTURE 2 0.0007
250 HYPERTONIC BLADDER 2 0.0007
251 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
252 LUMBAR SPINAL STENOSIS 2 0.0007
253 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
254 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 4 0.0007
255 GOUT 12 0.0007
256 DRUG LEVEL INCREASED 11 0.0007
257 MYELOFIBROSIS 2 0.0007
258 VASCULAR DEVICE INFECTION 3 0.0007
259 END STAGE RENAL DISEASE 12 0.0007
260 BUNDLE BRANCH BLOCK RIGHT 3 0.0007
261 DIABETIC FOOT 2 0.0007
262 INTRACARDIAC THROMBUS 2 0.0007
263 IRON DEFICIENCY ANAEMIA 6 0.0006
264 PERFORMANCE STATUS DECREASED 3 0.0006
265 TASTE DISORDER 13 0.0006
266 PNEUMONIA ASPIRATION 16 0.0006
267 BLOOD PRESSURE INCREASED 97 0.0006
268 NON-CARDIAC CHEST PAIN 2 0.0006
269 ORTHOPNOEA 2 0.0006
270 NON-SMALL CELL LUNG CANCER 3 0.0006
271 PORTAL VEIN THROMBOSIS 2 0.0006
272 BLOOD PRESSURE SYSTOLIC INCREASED 12 0.0006
273 CEREBRAL HAEMORRHAGE 22 0.0006
274 SPRUE-LIKE ENTEROPATHY 3 0.0006
275 DYSGRAPHIA 4 0.0006
276 SPINAL COMPRESSION FRACTURE 5 0.0006
277 HYPERNATRAEMIA 3 0.0006
278 EOSINOPHIL COUNT INCREASED 5 0.0006
279 ATRIOVENTRICULAR BLOCK COMPLETE 4 0.0006
280 CEREBRAL HAEMATOMA 2 0.0006
281 TOXIC EPIDERMAL NECROLYSIS 9 0.0006
282 TOXIC ENCEPHALOPATHY 3 0.0006
283 SUBARACHNOID HAEMORRHAGE 6 0.0006
284 HEPATIC CYST 2 0.0006
285 CHOLECYSTITIS 7 0.0006
286 CARDIAC FAILURE 47 0.0006
287 FEMORAL NECK FRACTURE 3 0.0006
288 BRONCHOPNEUMONIA 2 0.0006
289 PRIAPISM 2 0.0006
290 TUMOUR LYSIS SYNDROME 5 0.0006
291 NECROTISING FASCIITIS 2 0.0006
292 JAUNDICE CHOLESTATIC 2 0.0006
293 PURPURA 5 0.0006
294 LIVER DISORDER 25 0.0006
295 HAEMORRHAGIC DIATHESIS 2 0.0006
296 PRODUCT SIZE ISSUE 3 0.0006
297 ANAL INCONTINENCE 5 0.0006
298 HYPERTHYROIDISM 8 0.0006
299 CAROTID ARTERY OCCLUSION 2 0.0005
300 CEREBRAL DISORDER 4 0.0005
301 ARTERIOSCLEROSIS 5 0.0005
302 BLOOD SODIUM DECREASED 10 0.0005
303 PRODUCT PACKAGING ISSUE 5 0.0005
304 THYROID DISORDER 8 0.0005
305 SINUS BRADYCARDIA 5 0.0005
306 KNEE OPERATION 5 0.0005
307 DRUG ERUPTION 9 0.0005
308 POLYDIPSIA 2 0.0005
309 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
310 PLEURISY 3 0.0005
311 BLOOD ALBUMIN DECREASED 4 0.0005
312 AZOTAEMIA 2 0.0005
313 BLOOD PRESSURE FLUCTUATION 12 0.0005
314 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
315 FOREIGN BODY 2 0.0005
316 BLOOD POTASSIUM DECREASED 15 0.0005
317 TYPE 1 DIABETES MELLITUS 3 0.0005
318 HYPONATRAEMIA 28 0.0005
319 SENSORY LOSS 4 0.0005
320 PRODUCT PHYSICAL ISSUE 10 0.0005
321 ASPHYXIA 4 0.0005
322 SUBDURAL HAEMATOMA 7 0.0005
323 GOITRE 2 0.0005
324 METASTASES TO BONE 8 0.0005
325 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
326 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
327 HYPERBILIRUBINAEMIA 5 0.0005
328 HEMIPLEGIA 4 0.0005
329 PLATELET COUNT DECREASED 51 0.0005
330 DRUG-INDUCED LIVER INJURY 15 0.0005
331 BLOOD UREA INCREASED 8 0.0005
332 INCONTINENCE 5 0.0005
333 BUNDLE BRANCH BLOCK LEFT 2 0.0005
334 PRODUCT DISPENSING ISSUE 2 0.0005
335 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
336 ABNORMAL SENSATION IN EYE 2 0.0005
337 BLOOD MAGNESIUM DECREASED 4 0.0005
338 ANGINA UNSTABLE 3 0.0005
339 CHRONIC KIDNEY DISEASE 35 0.0005
340 MONOPLEGIA 2 0.0005
341 SKIN LACERATION 5 0.0005
342 POLYP 3 0.0005
343 IMMOBILE 2 0.0005
344 URINE OUTPUT DECREASED 4 0.0005
345 WOUND INFECTION 5 0.0005
346 ASPIRATION 5 0.0005
347 BLOOD CALCIUM INCREASED 4 0.0005
348 PHARYNGEAL OEDEMA 7 0.0005
349 HAEMORRHAGIC ANAEMIA 2 0.0005
350 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
351 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
352 NEPHROPATHY TOXIC 5 0.0004
353 PLEURAL EFFUSION 27 0.0004
354 PRODUCT TASTE ABNORMAL 6 0.0004
355 REBOUND EFFECT 5 0.0004
356 ASCITES 13 0.0004
357 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
358 INTERNAL HAEMORRHAGE 5 0.0004
359 INJECTION SITE PAPULE 2 0.0004
360 SHOCK 10 0.0004
361 HYPOTENSION 87 0.0004
362 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
363 LARGE INTESTINE POLYP 3 0.0004
364 SPINAL PAIN 5 0.0004
365 DISSEMINATED INTRAVASCULAR COAGULATION 6 0.0004
366 SQUAMOUS CELL CARCINOMA 4 0.0004
367 COVID-19 PNEUMONIA 5 0.0004
368 COLITIS MICROSCOPIC 2 0.0004
369 VISUAL FIELD DEFECT 3 0.0004
370 DERMATITIS BULLOUS 3 0.0004
371 AUTOIMMUNE DISORDER 4 0.0004
372 DECREASED APPETITE 95 0.0004
373 CYSTITIS 13 0.0004
374 LOWER GASTROINTESTINAL HAEMORRHAGE 3 0.0004
375 OEDEMA 22 0.0004
376 ACUTE KIDNEY INJURY 62 0.0004
377 LIMB INJURY 11 0.0004
378 DEHYDRATION 54 0.0004
379 ARTHROPOD BITE 3 0.0004
380 HYPERVOLAEMIA 2 0.0004
381 DIABETIC NEUROPATHY 2 0.0004
382 ANEURYSM 2 0.0004
383 PRESCRIBED UNDERDOSE 8 0.0004
384 HYPOTONIA 4 0.0004
385 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
386 HYPOTHERMIA 4 0.0004
387 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
388 EYELID PTOSIS 4 0.0004
389 SLUGGISHNESS 4 0.0004
390 AMMONIA INCREASED 2 0.0004
391 HYPOGLYCAEMIA 19 0.0004
392 LIPASE INCREASED 3 0.0004
393 SEPTIC SHOCK 17 0.0004
394 URINARY RETENTION 13 0.0004
395 INJECTION SITE INDURATION 5 0.0004
396 VENTRICULAR EXTRASYSTOLES 4 0.0004
397 EYE DISCHARGE 4 0.0004
398 THERAPY PARTIAL RESPONDER 6 0.0004
399 APLASTIC ANAEMIA 2 0.0004
400 PRODUCT USE COMPLAINT 6 0.0004
401 INJECTION SITE DISCOMFORT 4 0.0004
402 JOINT DISLOCATION 4 0.0004
403 SUDDEN DEATH 4 0.0004
404 BREAST PAIN 4 0.0004
405 BLOOD BILIRUBIN INCREASED 10 0.0004
406 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 75 0.0004
407 THROAT TIGHTNESS 10 0.0004
408 NEUTROPHIL COUNT DECREASED 15 0.0004
409 HYDROCEPHALUS 2 0.0004
410 ASTHENOPIA 2 0.0004
411 INJECTION SITE NODULE 4 0.0004
412 EMBOLISM 3 0.0004
413 VENTRICULAR FIBRILLATION 4 0.0004
414 STEVENS-JOHNSON SYNDROME 8 0.0004
415 HYPERTENSIVE CRISIS 4 0.0004
416 ATRIAL FIBRILLATION 35 0.0004
417 DYSPHONIA 21 0.0004
418 CARPAL TUNNEL SYNDROME 5 0.0004
419 CHOLECYSTITIS ACUTE 2 0.0004
420 OEDEMA PERIPHERAL 43 0.0004
421 BLOOD PRESSURE ABNORMAL 7 0.0004
422 PERONEAL NERVE PALSY 2 0.0004
423 GRANULOCYTOPENIA 2 0.0004
424 ANGINA PECTORIS 10 0.0003
425 EXERCISE TOLERANCE DECREASED 2 0.0003
426 MOUTH SWELLING 2 0.0003
427 RENAL FAILURE 46 0.0003
428 ELECTROLYTE IMBALANCE 4 0.0003
429 LACTIC ACIDOSIS 11 0.0003
430 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 3 0.0003
431 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
432 CATARACT OPERATION 2 0.0003
433 THIRST 6 0.0003
434 COLON CANCER 5 0.0003
435 DIABETIC KETOACIDOSIS 8 0.0003
436 FEBRILE NEUTROPENIA 22 0.0003
437 LEUKOCYTOSIS 6 0.0003
438 STOMATITIS 20 0.0003
439 NOCTURIA 4 0.0003
440 HYPERGLYCAEMIA 12 0.0003
441 DERMATITIS ACNEIFORM 2 0.0003
442 DRUG DISPENSING ERROR 5 0.0003
443 HYPOKALAEMIA 15 0.0003
444 LARYNGEAL OEDEMA 2 0.0003
445 THINKING ABNORMAL 6 0.0003
446 ILEUS 4 0.0003
447 BACTERIAL INFECTION 6 0.0003
448 HEPATIC ENCEPHALOPATHY 3 0.0003
449 HAIR COLOUR CHANGES 4 0.0003
450 NEPHROPATHY 3 0.0003
451 INFUSION SITE EXTRAVASATION 2 0.0003
452 APPENDICITIS 3 0.0003
453 PEMPHIGUS 4 0.0003
454 NASAL DRYNESS 2 0.0003
455 HYPOCALCAEMIA 6 0.0003
456 DELIRIUM 11 0.0003
457 ARRHYTHMIA 15 0.0003
458 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
459 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
460 HYPOPHAGIA 8 0.0003
461 MALIGNANT NEOPLASM PROGRESSION 32 0.0003
462 PANCREATITIS ACUTE 7 0.0003
463 PROCTALGIA 2 0.0003
464 HYPERCHOLESTEROLAEMIA 3 0.0003
465 ALANINE AMINOTRANSFERASE INCREASED 19 0.0003
466 CARDIAC FLUTTER 2 0.0003
467 ANAEMIA 59 0.0003
468 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 22 0.0003
469 MUSCLE TIGHTNESS 5 0.0003
470 CHOKING 6 0.0003
471 PULMONARY CONGESTION 4 0.0003
472 PERICARDIAL EFFUSION 7 0.0003
473 C-REACTIVE PROTEIN INCREASED 11 0.0003
474 DIABETES MELLITUS 23 0.0003
475 APPETITE DISORDER 2 0.0003
476 LEFT VENTRICULAR DYSFUNCTION 2 0.0003
477 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
478 FEEDING DISORDER 6 0.0003
479 DRY THROAT 3 0.0003
480 ANGIOEDEMA 13 0.0003
481 DYSPNOEA EXERTIONAL 11 0.0003
482 SWELLING FACE 19 0.0003
483 ORAL DISCOMFORT 4 0.0003
484 RHABDOMYOLYSIS 12 0.0003
485 AUTOIMMUNE HEPATITIS 2 0.0003
486 HYPOMAGNESAEMIA 4 0.0003
487 METASTASES TO LIVER 5 0.0003
488 DUODENAL ULCER 2 0.0003
489 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
490 LYMPHOCYTE COUNT DECREASED 5 0.0003
491 HEAD DISCOMFORT 5 0.0003
492 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
493 DIALYSIS 4 0.0003
494 IRRITABLE BOWEL SYNDROME 6 0.0003
495 BLOOD CHOLESTEROL INCREASED 13 0.0003
496 HEPATIC ENZYME INCREASED 19 0.0003
497 MUSCLE SPASMS 51 0.0003
498 CELLULITIS 14 0.0003
499 MYELOSUPPRESSION 10 0.0003
500 GLYCOSYLATED HAEMOGLOBIN INCREASED 7 0.0003
501 PARAESTHESIA ORAL 4 0.0003
502 PRODUCT DOSE OMISSION 18 0.0003
503 GASTROENTERITIS 4 0.0003
504 BLOOD GLUCOSE FLUCTUATION 3 0.0003
505 ORAL DISORDER 2 0.0003
506 MOUTH HAEMORRHAGE 2 0.0003
507 ANAPHYLACTIC SHOCK 7 0.0003
508 PSYCHIATRIC SYMPTOM 2 0.0003
509 SKIN ULCER 7 0.0003
510 CARDIOMYOPATHY 4 0.0003
511 HYPOPHOSPHATAEMIA 2 0.0003
512 DIPLOPIA 7 0.0003
513 DUODENAL ULCER PERFORATION 2 0.0003
514 JOINT STIFFNESS 7 0.0003
515 TRANSIENT ISCHAEMIC ATTACK 9 0.0003
516 PAROSMIA 2 0.0003
517 MITRAL VALVE INCOMPETENCE 3 0.0003
518 APHASIA 8 0.0003
519 DIZZINESS 132 0.0003
520 ECONOMIC PROBLEM 4 0.0003
521 POLLAKIURIA 11 0.0003
522 PRODUCT AVAILABILITY ISSUE 6 0.0003
523 HAEMOGLOBIN DECREASED 27 0.0003
524 DIARRHOEA 169 0.0003
525 FOOD ALLERGY 2 0.0003
526 ATRIOVENTRICULAR BLOCK 2 0.0003
527 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
528 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
529 PELVIC FRACTURE 2 0.0003
530 ATAXIA 3 0.0003
531 SINUS DISORDER 5 0.0003
532 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
533 FURUNCLE 2 0.0003
534 PANCYTOPENIA 14 0.0003
535 LOSS OF CONSCIOUSNESS 32 0.0002
536 DRY MOUTH 20 0.0002
537 MUSCULAR WEAKNESS 28 0.0002
538 BONE MARROW FAILURE 5 0.0002
539 DECUBITUS ULCER 2 0.0002
540 POLYURIA 2 0.0002
541 CARDIOMEGALY 3 0.0002
542 HICCUPS 2 0.0002
543 SPINAL OPERATION 3 0.0002
544 HYPERCALCAEMIA 3 0.0002
545 OSTEONECROSIS OF JAW 6 0.0002
546 DYSPHAGIA 23 0.0002
547 CYST 3 0.0002
548 TOOTH EXTRACTION 3 0.0002
549 CYTOMEGALOVIRUS INFECTION 4 0.0002
550 LIP SWELLING 8 0.0002
551 PRODUCT STORAGE ERROR 21 0.0002
552 COVID-19 42 0.0002
553 GAIT INABILITY 8 0.0002
554 FEELING ABNORMAL 57 0.0002
555 ACUTE MYOCARDIAL INFARCTION 7 0.0002
556 GASTRIC CANCER 6 0.0002
557 EATING DISORDER 5 0.0002
558 URINARY TRACT INFECTION 40 0.0002
559 ROTATOR CUFF SYNDROME 3 0.0002
560 PRODUCT CONTAINER ISSUE 2 0.0002
561 LIVER FUNCTION TEST INCREASED 5 0.0002
562 METASTASES TO CENTRAL NERVOUS SYSTEM 3 0.0002
563 MUSCULOSKELETAL DISCOMFORT 4 0.0002
564 HEART RATE INCREASED 23 0.0002
565 RASH GENERALISED 6 0.0002
566 NEUROPATHY PERIPHERAL 22 0.0002
567 NEOPLASM PROGRESSION 8 0.0002
568 ORTHOSTATIC HYPOTENSION 4 0.0002
569 GROIN PAIN 2 0.0002
570 IMMUNE SYSTEM DISORDER 3 0.0002
571 GRIP STRENGTH DECREASED 2 0.0002
572 PERIPHERAL SWELLING 35 0.0002
573 SARS-COV-2 TEST POSITIVE 3 0.0002
574 MALAISE 99 0.0002
575 ISCHAEMIC STROKE 4 0.0002
576 PULMONARY OEDEMA 10 0.0002
577 MYOSITIS 2 0.0002
578 CHROMATURIA 5 0.0002
579 HEART RATE IRREGULAR 5 0.0002
580 CONSTIPATION 48 0.0002
581 SYNCOPE 22 0.0002
582 RESPIRATORY FAILURE 16 0.0002
583 TREATMENT NONCOMPLIANCE 12 0.0002
584 UNDERDOSE 16 0.0002
585 RESTLESSNESS 8 0.0002
586 INCREASED TENDENCY TO BRUISE 2 0.0002
587 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
588 NERVE COMPRESSION 2 0.0002
589 EYE SWELLING 8 0.0002
590 DEMENTIA 6 0.0002
591 RENAL DISORDER 10 0.0002
592 HEPATIC CIRRHOSIS 4 0.0002
593 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
594 FRACTURE 4 0.0002
595 SINUS TACHYCARDIA 3 0.0002
596 COLITIS 8 0.0002
597 EXPIRED PRODUCT ADMINISTERED 7 0.0002
598 GASTRIC ULCER 4 0.0002
599 INTENTIONAL DOSE OMISSION 6 0.0002
600 SPEECH DISORDER 11 0.0002
601 SKIN DISORDER 7 0.0002
602 SLEEP APNOEA SYNDROME 4 0.0002
603 LETHARGY 12 0.0002
604 PRESCRIBED OVERDOSE 4 0.0002
605 LIVER FUNCTION TEST ABNORMAL 6 0.0002
606 DIZZINESS POSTURAL 2 0.0002
607 PRESYNCOPE 5 0.0002
608 PHARYNGEAL SWELLING 2 0.0002
609 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
610 ABDOMINAL DISCOMFORT 34 0.0002
611 HAEMATOCRIT DECREASED 4 0.0002
612 BLADDER DISORDER 2 0.0002
613 INABILITY TO AFFORD MEDICATION 2 0.0002
614 COLITIS ULCERATIVE 9 0.0002
615 PNEUMONIA 65 0.0002
616 SPINAL FRACTURE 4 0.0002
617 HEART RATE DECREASED 7 0.0002
618 CARDIAC FAILURE CONGESTIVE 16 0.0002
619 FALL 66 0.0002
620 FLUID RETENTION 10 0.0002
621 DRUG LEVEL DECREASED 2 0.0002
622 MOTOR DYSFUNCTION 2 0.0002
623 FEELING HOT 12 0.0002
624 DRUG INTERACTION 31 0.0002
625 EYE PAIN 11 0.0002
626 DEVICE RELATED INFECTION 3 0.0002
627 EAR DISCOMFORT 2 0.0002
628 RIB FRACTURE 4 0.0002
629 DISEASE PROGRESSION 23 0.0002
630 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
631 FLATULENCE 11 0.0002
632 VISUAL IMPAIRMENT 24 0.0002
633 HERPES ZOSTER 11 0.0002
634 DEAFNESS 5 0.0002
635 GASTRITIS 5 0.0002
636 PNEUMOTHORAX 3 0.0002
637 BRADYCARDIA 10 0.0002
638 OBESITY 3 0.0002
639 SCIATICA 3 0.0002
640 RETCHING 4 0.0002
641 DECREASED ACTIVITY 2 0.0002
642 WHITE BLOOD CELL COUNT DECREASED 20 0.0002
643 SOMNOLENCE 37 0.0002
644 PNEUMONITIS 5 0.0002
645 IMPAIRED HEALING 6 0.0002
646 VENTRICULAR TACHYCARDIA 3 0.0002
647 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
648 ANAPHYLACTIC REACTION 10 0.0002
649 PSYCHOMOTOR HYPERACTIVITY 3 0.0002
650 RASH MACULO-PAPULAR 4 0.0002
651 HAEMOPTYSIS 5 0.0002
652 PYREXIA 62 0.0002
653 RASH PAPULAR 4 0.0002
654 OCULAR DISCOMFORT 2 0.0002
655 BLOOD CALCIUM DECREASED 2 0.0002
656 DEPRESSED LEVEL OF CONSCIOUSNESS 7 0.0002
657 PAIN IN JAW 5 0.0002
658 DERMATITIS CONTACT 2 0.0002
659 ABDOMINAL PAIN UPPER 36 0.0002
660 NEOPLASM 2 0.0002
661 GASTRIC HAEMORRHAGE 2 0.0002
662 EYELID OEDEMA 2 0.0002
663 ECZEMA 9 0.0002
664 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
665 SEPSIS 19 0.0002
666 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
667 HEADACHE 106 0.0002
668 RENAL INJURY 5 0.0002
669 DISEASE RECURRENCE 8 0.0002
670 PRODUCT PRESCRIBING ERROR 4 0.0002
671 BACK PAIN 39 0.0002
672 HYPOAESTHESIA 25 0.0002
673 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
674 HEPATIC CANCER 4 0.0002
675 GASTROENTERITIS VIRAL 3 0.0002
676 RASH PRURITIC 9 0.0002
677 INFUSION RELATED REACTION 11 0.0002
678 HEPATIC FAILURE 5 0.0002
679 OSTEOMYELITIS 3 0.0002
680 NAUSEA 131 0.0002
681 LACRIMATION INCREASED 5 0.0002
682 THERAPEUTIC RESPONSE DECREASED 10 0.0002
683 EPILEPSY 5 0.0002
684 CYTOPENIA 2 0.0002
685 ABDOMINAL DISTENSION 17 0.0002
686 PALPITATIONS 19 0.0002
687 LIMB DISCOMFORT 5 0.0002
688 AGRANULOCYTOSIS 3 0.0002
689 MIDDLE INSOMNIA 3 0.0002
690 SWELLING 15 0.0002
691 SWOLLEN TONGUE 5 0.0002
692 POISONING 2 0.0002
693 DERMATITIS ALLERGIC 2 0.0002
694 ARTHRALGIA 66 0.0002
695 UNEVALUABLE EVENT 12 0.0002
696 MUSCLE ATROPHY 2 0.0002
697 CARDIAC ARREST 13 0.0002
698 PULMONARY FIBROSIS 3 0.0002
699 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
700 METABOLIC ACIDOSIS 5 0.0002
701 PRODUCT SUBSTITUTION ISSUE 9 0.0002
702 GLAUCOMA 3 0.0002
703 ERECTILE DYSFUNCTION 4 0.0002
704 VOMITING 73 0.0002
705 INFLAMMATION 8 0.0002
706 PRODUCT QUALITY ISSUE 21 0.0002
707 PRODUCT USE ISSUE 29 0.0002
708 SKIN FISSURES 3 0.0002
709 PAIN IN EXTREMITY 45 0.0002
710 NEPHROLITHIASIS 7 0.0002
711 CHOLELITHIASIS 5 0.0002
712 INFLUENZA 17 0.0002
713 TINNITUS 7 0.0002
714 EYE DISORDER 5 0.0002
715 STAPHYLOCOCCAL INFECTION 5 0.0002
716 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
717 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
718 UPPER LIMB FRACTURE 3 0.0002
719 WEIGHT DECREASED 42 0.0002
720 COGNITIVE DISORDER 7 0.0001
721 EYE HAEMORRHAGE 2 0.0001
722 HAIR TEXTURE ABNORMAL 2 0.0001
723 INJECTION SITE PRURITUS 10 0.0001
724 FULL BLOOD COUNT DECREASED 3 0.0001
725 PAIN OF SKIN 4 0.0001
726 DISTURBANCE IN ATTENTION 8 0.0001
727 DYSKINESIA 6 0.0001
728 EPISTAXIS 11 0.0001
729 OSTEOPOROSIS 6 0.0001
730 CORONARY ARTERY OCCLUSION 2 0.0001
731 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
732 VISION BLURRED 20 0.0001
733 PROSTATIC SPECIFIC ANTIGEN INCREASED 2 0.0001
734 FATIGUE 113 0.0001
735 DRUG INTOLERANCE 14 0.0001
736 DIVERTICULITIS 4 0.0001
737 PULMONARY HYPERTENSION 3 0.0001
738 FEELING COLD 4 0.0001
739 CARDIO-RESPIRATORY ARREST 6 0.0001
740 COORDINATION ABNORMAL 2 0.0001
741 APHONIA 2 0.0001
742 DERMATITIS 3 0.0001
743 WOUND 4 0.0001
744 BURNING SENSATION 10 0.0001
745 HALLUCINATION, VISUAL 3 0.0001
746 BLINDNESS UNILATERAL 2 0.0001
747 LYMPHADENOPATHY 5 0.0001
748 ASTHENIA 53 0.0001
749 INTENTIONAL OVERDOSE 9 0.0001
750 DRY EYE 7 0.0001
751 BRONCHOSPASM 2 0.0001
752 RASH 61 0.0001
753 PARALYSIS 2 0.0001
754 CARDIOGENIC SHOCK 2 0.0001
755 POOR QUALITY SLEEP 3 0.0001
756 COUGH 39 0.0001
757 SEIZURE 16 0.0001
758 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
759 WEIGHT INCREASED 31 0.0001
760 FAECES DISCOLOURED 3 0.0001
761 AMNESIA 9 0.0001
762 APATHY 2 0.0001
763 DYSSTASIA 4 0.0001
764 THERAPY CESSATION 7 0.0001
765 MYALGIA 23 0.0001
766 CHEST PAIN 25 0.0001
767 DYSGEUSIA 10 0.0001
768 IMMUNODEFICIENCY 2 0.0001
769 ORAL PAIN 3 0.0001
770 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
771 HAEMORRHAGE 14 0.0001
772 HAEMORRHAGE INTRACRANIAL 2 0.0001
773 RESPIRATORY DISORDER 4 0.0001
774 HALLUCINATION 10 0.0001
775 BLOOD GLUCOSE INCREASED 25 0.0001
776 PRODUCT DOSE OMISSION ISSUE 39 0.0001
777 JOINT SWELLING 16 0.0001
778 DEPRESSED MOOD 7 0.0001
779 CORONARY ARTERY DISEASE 4 0.0001
780 HYPERHIDROSIS 17 0.0001
781 OSTEOPENIA 2 0.0001
782 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
783 OFF LABEL USE 115 0.0001
784 GAIT DISTURBANCE 25 0.0001
785 HIP ARTHROPLASTY 2 0.0001
786 SKIN DISCOLOURATION 6 0.0001
787 GYNAECOMASTIA 4 0.0001
788 MUSCULOSKELETAL CHEST PAIN 2 0.0001
789 FEMUR FRACTURE 4 0.0001
790 CONDITION AGGRAVATED 39 0.0001
791 BASAL CELL CARCINOMA 2 0.0001
792 NERVOUS SYSTEM DISORDER 4 0.0001
793 BRAIN FOG 2 0.0001
794 SLEEP DISORDER 9 0.0001
795 ALOPECIA 25 0.0001
796 BALANCE DISORDER 11 0.0001
797 CYANOSIS 2 0.0001
798 HAEMATOCHEZIA 7 0.0001
799 DISORIENTATION 5 0.0001
800 ARTHROPATHY 7 0.0001
801 ABSCESS 2 0.0001
802 THROMBOCYTOPENIA 14 0.0001
803 MOVEMENT DISORDER 4 0.0001
804 ASTHMA 14 0.0001
805 MENTAL IMPAIRMENT 3 0.0001
806 CONFUSIONAL STATE 20 0.0001
807 DYSPNOEA 70 0.0001
808 HOSPITALISATION 19 0.0001
809 DEEP VEIN THROMBOSIS 8 0.0001
810 BACK DISORDER 2 0.0001
811 PRURITUS 47 0.0001
812 ENCEPHALOPATHY 3 0.0001
813 LUNG NEOPLASM MALIGNANT 5 0.0001
814 ABASIA 3 0.0001
815 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
816 TREMOR 20 0.0001
817 COAGULOPATHY 2 0.0001
818 NASOPHARYNGITIS 22 0.0001
819 ABDOMINAL PAIN LOWER 3 0.0001
820 SKIN EXFOLIATION 10 0.0001
821 CIRCULATORY COLLAPSE 2 0.0001
822 HAEMATURIA 4 0.0001
823 RESPIRATORY TRACT INFECTION 3 0.0001
824 VERTIGO 7 0.0001
825 ANHEDONIA 3 0.0001
826 INTENTIONAL PRODUCT USE ISSUE 10 0.0001
827 EOSINOPHILIA 2 0.0001
828 TACHYCARDIA 10 0.0001
829 THERAPY NON-RESPONDER 5 0.0001
830 CHILLS 13 0.0001
831 DRUG EFFECT INCOMPLETE 4 0.0001
832 DYSURIA 4 0.0001
833 RHINORRHOEA 7 0.0001
834 BLOOD GLUCOSE ABNORMAL 2 0.0001
835 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
836 BRONCHITIS 8 0.0001
837 PARAESTHESIA 17 0.0001
838 CHEST DISCOMFORT 11 0.0001
839 HEPATIC STEATOSIS 2 0.0001
840 NECK PAIN 6 0.0001
841 CARDIAC DISORDER 10 0.0001
842 BLISTER 6 0.0001
843 OXYGEN SATURATION DECREASED 6 0.0001
844 FOOT FRACTURE 2 0.0001
845 OCULAR HYPERAEMIA 5 0.0001
846 INTERNATIONAL NORMALISED RATIO INCREASED 3 0.0001
847 PRODUCTIVE COUGH 5 0.0001
848 LOWER LIMB FRACTURE 2 0.0001
849 CONTUSION 10 0.0001
850 ERUCTATION 2 0.0001
851 INTENTIONAL PRODUCT MISUSE 9 0.0001
852 MUSCULOSKELETAL STIFFNESS 9 0.0001
853 ORAL HERPES 2 0.0001
854 DRUG INEFFECTIVE 135 0.0001
855 BONE PAIN 6 0.0001
856 SURGERY 6 0.0001
857 ARTHRITIS 8 0.0001
858 DISABILITY 2 0.0001
859 INTENTIONAL SELF-INJURY 2 0.0001
860 PRODUCT ADMINISTRATION ERROR 2 0.0001
861 PSORIATIC ARTHROPATHY 4 0.0001
862 BODY TEMPERATURE INCREASED 2 0.0001
863 DRUG ADMINISTRATION ERROR 3 0.0001
864 INSOMNIA 26 0.0001
865 INJECTION SITE WARMTH 2 0.0001
866 PERITONITIS 2 0.0001
867 KNEE ARTHROPLASTY 2 0.0001
868 MOUTH ULCERATION 2 0.0001
869 PULMONARY EMBOLISM 9 0.0001
870 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
871 MIGRAINE 9 0.0001
872 HOT FLUSH 7 0.0001
873 ERYTHEMA 19 0.0001
874 DEVICE DISLOCATION 4 0.0001
875 MYOCARDIAL INFARCTION 16 0.0001
876 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
877 DYSPEPSIA 9 0.0001
878 ANXIETY 26 0.0001
879 MELAENA 2 0.0001
880 APPLICATION SITE PAIN 2 0.0001
881 FUNGAL INFECTION 3 0.0001
882 INFECTION 13 0.0001
883 GLOSSODYNIA 2 0.0001
884 GASTROINTESTINAL DISORDER 8 0.0001
885 EYE PRURITUS 3 0.0001
886 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
887 THROAT IRRITATION 4 0.0001
888 TYPE 2 DIABETES MELLITUS 3 0.0001
889 CEREBROVASCULAR ACCIDENT 15 0.0001
890 APPLICATION SITE PRURITUS 2 0.0001
891 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
892 SINUSITIS 9 0.0001
893 GASTRIC DISORDER 3 0.0001
894 MUSCLE TWITCHING 2 0.0001
895 HYPERSENSITIVITY 16 0.0001
896 RASH MACULAR 3 0.0001
897 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 6 0.0001
898 WHEEZING 5 0.0001
899 THERAPY INTERRUPTED 6 0.0001
900 RASH ERYTHEMATOUS 4 0.0001
901 URTICARIA 14 0.0001
902 MOBILITY DECREASED 6 0.0001
903 BLOOD GLUCOSE DECREASED 4 0.0001
904 SUICIDE ATTEMPT 5 0.0001
905 DRY SKIN 11 0.0001
906 DISCOMFORT 5 0.0001
907 MEMORY IMPAIRMENT 11 0.0001
908 LEUKOPENIA 4 0.0001
909 DYSARTHRIA 3 0.0001
910 INTESTINAL OBSTRUCTION 3 0.0001
911 RHEUMATOID ARTHRITIS 9 0.0001
912 HAEMATEMESIS 2 0.0001
913 OVERDOSE 17 0.0001
914 DRUG DOSE OMISSION 13 0.0001
915 INJECTION SITE SWELLING 6 0.0001
916 HEPATITIS 2 0.0001
917 DRUG RESISTANCE 2 0.0001
918 HAEMATOMA 2 0.0001
919 PLASMA CELL MYELOMA 3 0.0001
920 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 4 0.0001
921 NERVOUSNESS 4 0.0001
922 ADVERSE EVENT 7 0.0001
923 NEOPLASM MALIGNANT 5 0.0001
924 BREAST CANCER FEMALE 2 0.0001
925 THROMBOSIS 6 0.0001
926 GASTROOESOPHAGEAL REFLUX DISEASE 6 0.0001
927 FEAR 2 0.0001
928 JAUNDICE 2 0.0001
929 FREQUENT BOWEL MOVEMENTS 2 0.0001
930 BLINDNESS 3 0.0001
931 PALLOR 2 0.0001
932 PRODUCT USE IN UNAPPROVED INDICATION 18 0.0001
933 ABNORMAL DREAMS 2 0.0001
934 MENTAL STATUS CHANGES 2 0.0001
935 OSTEOARTHRITIS 3 0.0001
936 RENAL FAILURE ACUTE 3 0.0001
937 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
938 CONVULSION 4 0.0001
939 RECTAL HAEMORRHAGE 3 0.0001
940 HYPOACUSIS 3 0.0001
941 EYE IRRITATION 4 0.0001
942 GENERAL PHYSICAL HEALTH DETERIORATION 8 0.0001
943 MENTAL DISORDER 3 0.0001
944 FLUSHING 7 0.0001
945 DEPRESSION 15 0.0001
946 ILL-DEFINED DISORDER 4 0.0001
947 OROPHARYNGEAL PAIN 6 0.0001
948 HEAD INJURY 2 0.0001
949 MOOD SWINGS 2 0.0001
950 DEATH 54 0.0001
951 NIGHT SWEATS 2 0.0001
952 ABDOMINAL PAIN 14 0.0001
953 ANGER 2 0.0001
954 NEUTROPENIA 8 0.0001
955 PAIN 36 0.0001
956 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
957 MUSCULOSKELETAL PAIN 3 0.0001
958 DERMATITIS ATOPIC 3 0.0001
959 HYPOXIA 2 0.0001
960 PANCREATITIS 3 0.0001
961 PRODUCT ADHESION ISSUE 2 0.0001
962 DRUG EFFECT DECREASED 3 0.0001
963 ACCIDENTAL OVERDOSE 2 0.0001
964 INCORRECT DOSE ADMINISTERED 12 0.0001
965 NASAL CONGESTION 3 0.0001
966 CATARACT 3 0.0001
967 INJECTION SITE BRUISING 4 0.0001
968 IRRITABILITY 3 0.0000
969 INJECTION SITE ERYTHEMA 6 0.0000
970 PSORIASIS 6 0.0000
971 ADVERSE DRUG REACTION 4 0.0000
972 INJURY 3 0.0000
973 SKIN BURNING SENSATION 3 0.0000
974 MULTIPLE SCLEROSIS 2 0.0000
975 EMOTIONAL DISTRESS 5 0.0000
976 ILLNESS 4 0.0000
977 INJECTION SITE HAEMORRHAGE 3 0.0000
978 PROSTATE CANCER 3 0.0000
979 INFLUENZA LIKE ILLNESS 3 0.0000
980 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
981 MEDICATION ERROR 2 0.0000
982 TOXICITY TO VARIOUS AGENTS 6 0.0000
983 NO ADVERSE EVENT 6 0.0000
984 BREAST CANCER 3 0.0000
985 EXPOSURE DURING PREGNANCY 2 0.0000
986 INJECTION SITE REACTION 2 0.0000
987 AGITATION 2 0.0000
988 ACNE 2 0.0000
989 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
990 INJECTION SITE PAIN 7 0.0000
991 DEVICE ISSUE 2 0.0000